Edwards Lifesciences CorporationEWNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+48.4%
5Y CAGR+17.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+48.4%/yr
vs -8.5%/yr prior
5Y CAGR
+17.9%/yr
Recent acceleration
Acceleration
+56.9pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 18.68% |
| 2024 | -3.41% |
| 2023 | -16.16% |
| 2022 | 5.71% |
| 2021 | 24.26% |
| 2020 | 8.19% |
| 2019 | 9.67% |
| 2018 | 8.14% |
| 2017 | 23.86% |
| 2016 | 41.60% |